126 related articles for article (PubMed ID: 2159372)
1. Effects of 1 alpha, 25-dihydroxyvitamin D3 on the human chronic myelogenous leukemia cell line RWLeu-4.
Lasky SR; Bell W; Huhn RD; Posner MR; Wiemann M; Calabresi P; Eil C
Cancer Res; 1990 May; 50(10):3087-94. PubMed ID: 2159372
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a vitamin D3-resistant human chronic myelogenous leukemia cell line.
Lasky SR; Posner MR; Iwata K; Santos-Moore A; Yen A; Samuel V; Clark J; Maizel AL
Blood; 1994 Dec; 84(12):4283-94. PubMed ID: 7994044
[TBL] [Abstract][Full Text] [Related]
3. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
Yamamoto-Yamaguchi Y; Makishima M; Kanatani Y; Kasukabe T; Honma Y
Exp Hematol; 1996 May; 24(6):682-9. PubMed ID: 8635523
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of JunD by dihydroxycholecalciferol in human chronic myelogenous leukemia cells.
Lasky SR; Iwata K; Rosmarin AG; Caprio DG; Maizel AL
J Biol Chem; 1995 Aug; 270(34):19676-9. PubMed ID: 7649976
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of vitamin D receptors in clonal populations of a chronic myelogenous leukemia cell line.
Iwata K; Kouttab N; Ogata H; Morgan JW; Maizel AL; Lasky SR
Exp Cell Res; 1996 May; 225(1):143-50. PubMed ID: 8635507
[TBL] [Abstract][Full Text] [Related]
6. Effects of analogs of 1,25(OH)2 vitamin D3 on the proliferation and differentiation of the human chronic myelogenous leukemia cell line, RWLeu-4.
Clark JW; Posner MR; Marsella JM; Santos A; Uskokovic M; Eil C; Lasky SR
J Cancer Res Clin Oncol; 1992; 118(3):190-4. PubMed ID: 1372318
[TBL] [Abstract][Full Text] [Related]
7. Hormonal responses to 1,25-dihydroxyvitamin D3 in cultured mouse osteoblast-like cells--modulation by changes in receptor level.
Chen TL; Li JM; Ye TV; Cone CM; Feldman D
J Cell Physiol; 1986 Jan; 126(1):21-8. PubMed ID: 3003120
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
[TBL] [Abstract][Full Text] [Related]
9. l-Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH)
Song JH; Park E; Kim MS; Cho KM; Park SH; Lee A; Song J; Kim HJ; Koh JT; Kim TS
Int J Cancer; 2017 May; 140(10):2364-2374. PubMed ID: 28224619
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
Nagasaki T; Hino M; Inaba M; Nishizawa Y; Morii H; Otani S
Arch Biochem Biophys; 1997 Jul; 343(2):181-7. PubMed ID: 9224728
[TBL] [Abstract][Full Text] [Related]
11. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses.
Chen TL; Hauschka PV; Cabrales S; Feldman D
Endocrinology; 1986 Jan; 118(1):250-9. PubMed ID: 3000737
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.
Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K
Exp Hematol; 1995 Oct; 23(11):1153-9. PubMed ID: 7556524
[TBL] [Abstract][Full Text] [Related]
13. Expression of BCR - ABL in M1 myeloid leukemia cells induces differentiation without arresting proliferation.
Cambier N; Zhang Y; Vairo G; Kosmopoulos K; Metcalf D; Nicola NA; Elefanty AG
Oncogene; 1999 Jan; 18(2):343-52. PubMed ID: 9927191
[TBL] [Abstract][Full Text] [Related]
14. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells.
Zhao X; Feldman D
Endocrinology; 1993 Apr; 132(4):1808-14. PubMed ID: 8384998
[TBL] [Abstract][Full Text] [Related]
15. Antioxidants and doxorubicin supplementation to modulate CD14 expression and oxidative stress induced by vitamin D3 and seocalcitol in HL60 cells.
Bondza-Kibangou P; Millot C; El Khoury V; Millot JM
Oncol Rep; 2007 Dec; 18(6):1513-9. PubMed ID: 17982638
[TBL] [Abstract][Full Text] [Related]
16. Tyrphostin induced growth inhibition: correlation with effect on p210bcr-abl autokinase activity in K562 chronic myelogenous leukemia.
Kaur G; Gazit A; Levitzki A; Stowe E; Cooney DA; Sausville EA
Anticancer Drugs; 1994 Apr; 5(2):213-22. PubMed ID: 8049505
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of vitamin D receptor expression in a human megakaryoblastic leukemia cell line: regulation of vitamin D receptor mRNA expression and responsiveness by forskolin.
Song LN
J Steroid Biochem Mol Biol; 1996 Mar; 57(5-6):265-74. PubMed ID: 8639462
[TBL] [Abstract][Full Text] [Related]
18. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
19. Modulation of CD157 expression in multi-lineage myeloid differentiation of promyelocytic cell lines.
Hussain AM; Lee HC; Chang CF
Eur J Cell Biol; 2000 Oct; 79(10):697-706. PubMed ID: 11089918
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells.
Zheng X; Chang RL; Cui XX; Kelly KA; Shih WJ; Lin Y; Strair R; Suh J; Han ZT; Rabson A; Conney AH
Oncol Res; 2000; 12(9-10):419-27. PubMed ID: 11697820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
